N/A
N=55
Visual and Electromyography Assessments in Response to Train-of-Four Stimulation of the Ulnar Nerve
Residual Neuromuscular Blockade
Bottom Line
View on ClinicalTrials.gov: NCT04352127 ↗Enrolled (actual)
55
Serious AEs
0.0%
Results posted
May 2022
Primary outcome: Primary: Subjective Evaluation to Neurostimulation — 48.2; 44.8 percentage of evaluations
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- TetraGraph (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Mayo Clinic
- Primary completion
- Jun 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Subjective Evaluation to Neurostimulation |
48.2; 44.8 | — |
| SECONDARY Incidence of Residual Neuromuscular Blockade |
1; 0 | — |
Summary
Researchers are comparing the accuracy of measuring muscle relaxation during and after surgery with a device that provides numeric value versus visual observation to count of muscle twitches or absence of them by a medical provider monitoring your anesthesia during surgery.
Eligibility Criteria
Inclusion Criteria
- Age > or = 18 years old
- Patients willing to participate and provide an informed consent
- Patients undergoing an elective surgical procedure that requires use of NMBA agents administered intraoperatively.
Exclusion Criteria
- Patients with disorders, such as stroke, carpal tunnel syndrome, broken wrist with nerve damage, Dupuytren contracture, or any similar wrist injury.
- Patients with systemic neuromuscular diseases such as myasthenia gravis
- Patients with significant organ dysfunction that can significantly affect pharmacokinetics of neuromuscular blocking and reversal agents, i.e., severe renal impairment or end-stage liver disease.
- Patients having surgery that would involve prepping the arm or leg into the sterile field
Data sourced from ClinicalTrials.gov (NCT04352127). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.